[Advantages and challenges of auxiliary liver transplantation therapeutic strategies for patients with acute liver failure]. [PDF]
Zhonghua Gan Zang Bing Za ZhiSun LY +5 more
europepmc +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 2013 【目的】 观察骨髓MSC联合NK细胞输注对小鼠异基因骨髓移植后aGVHD的影响,初步探讨其作用机制?【方法】 分离C57BL/6小鼠骨髓细胞,体外培养MSC;取C57BL/6小鼠脾脏细胞,磁珠分选NK细胞;建立C57BL/6→BALB/c小鼠异基因骨髓移植模型,接受移植小鼠随机分为4组,每组10只小鼠,MSC和NK细胞移植组,MSC移植组,NK细胞移植组和培养基对照组?根据aGVHD分值,肝?脾?小肠aGVHD病理损害和平均存活时间,评价aGVHD的程度?ELISA法检测小鼠血清中IFNγ和IL ...
doaj
[Clinical outcomes of small-size grafts in auxiliary liver transplantation for the treatment of portal hypertension]. [PDF]
Zhonghua Gan Zang Bing Za ZhiJu HF +9 more
europepmc +1 more source
[Novel research horizon for liver transplantation management model in hepatocellular carcinoma based on the tumor-donor liver-recipient]. [PDF]
Zhonghua Gan Zang Bing Za ZhiXu SJ, Xu YY, Xu X.
europepmc +1 more source
[17-year study on the curative effect of treatment to prevent the recurrence of hepatitis B in different risk groups after liver transplantation]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhang DL +7 more
europepmc +1 more source
[Research progress in the field of liver failure with artificial livers in 2025]. [PDF]
Zhonghua Gan Zang Bing Za ZhiHan T.
europepmc +1 more source
[Research progresses in ex vivo liver perfusion technology]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLiu QY, Zhao Q, He XS.
europepmc +1 more source
[Research progress on bioartificial liver]. [PDF]
Zhonghua Gan Zang Bing Za ZhiJiang Q, Su YS, Cao XY, Zhang HN, Li LJ.
europepmc +1 more source
[Impact of key indicator dynamic change on 90-day prognosis for patients with acute-on-chronic liver failure]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang WL +5 more
europepmc +1 more source
[Progress in antiviral treatment of hepatitis C after liver transplantation]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2020 Wang JY, Wei L, Huang Y, Dong JH.
europepmc +1 more source